IGC to be Featured in Feb. 10 Radius Research Investor Webinar
08 févr. 2023 08h30 HE
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Feb. 08, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces that Ram Mukunda, CEO, and Claudia...
Global Acne Medication Market to generate USD 14.26 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
07 févr. 2023 09h00 HE
|
Next Move Strategy Consulting
New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the Acne Medication Market generated USD 10.08 billion in 2021, and is projected to...
PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New Drug Application of KETARX™ (Ketamine) On-Body Pump System
07 févr. 2023 07h59 HE
|
PharmaTher Holdings Ltd.
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in advancing specialty ketamine pharmaceuticals, today...
Drug Discovery Services Market is expected to grow at 15.6 percent reaching 53.58 Bn by 2029, Regional Analysis, Competitive Landscape and Regional Analysis
03 févr. 2023 05h26 HE
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research, a leading Healthcare research, and consultancy firm have a business intelligence report on the emerging “Drug Discovery Services...
Global Allergy Diagnostic Market Anticipated to Generate a Revenue of $16,714.2 Million and Rise at a CAGR of 13.2% during the Estimated Timeframe 2022-2031 [250-Pages] | Exclusive by Research Dive
12 janv. 2023 09h00 HE
|
Research Dive
New York, USA, Jan. 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global allergy diagnostic market is envisioned to garner $16,714.2 million in revenue and grow...
Drug Repurposing Market 2023 Will Revenue to Cross reach US$ 30920 million by 2028 Research by Business Opportunities, Top Companies report covers, Market-specific challenges, consumption by Regional data
10 janv. 2023 06h12 HE
|
Proficient Market Insights
Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- "Drug Repurposing Market" research report focus on overall information that can help to take decisions on current market situation. Drug Repurposing Market...
Lantern Pharma to Participate at the RHK Capital Disruptive Growth Conference on December 5 at 12:00 p.m. ET
02 déc. 2022 08h00 HE
|
Lantern Pharma Inc.
DALLAS, Dec. 02, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Lantern Pharma Inc (Nasdaq: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence...
Societal CDMO Reports Third Quarter 2022 Financial Results
09 nov. 2022 16h05 HE
|
Societal CDMO, Inc.
Recorded Q3 Revenue of $21.6 Million, a 19% Increase Compared to Prior Year Period Entered into Real Estate Sales and Purchase Agreement Expected to Generate Proceeds of More than $9 Million Signed...
Societal CDMO to Report Financial Results for Third Quarter 2022 on November 9, 2022
02 nov. 2022 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Awarded Two New CDMO Service Contracts Focused on Supporting Ongoing Clinical Development Programs for Novel Therapeutic Candidates
07 sept. 2022 07h00 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...